vimarsana.com

Page 50 - அமெரிக்கன் ஆரோக்கியம் ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine found to be effective against Brazilian P 1 variant

Photo by Dreamstime The inactivated vaccine, CoronaVac, proved effective in combatting COVID-19 in the city of Manaus, Brazil, where the highly transmissible P.1 variant emerged and has devastated the local population, researchers from Brazil and the Yale School of Public Health have found. CoronaVac was shown to be 50% effective in preventing illness 14 days after administration of the first dose in its two-dose schedule. The study was conducted among nearly 70,000 health care workers in Manaus, which was the epicenter for the emergence of the P.1 variant. It is the first study to evaluate the effectiveness of a COVID-19 vaccine in places where P.1, often referred to as the “Brazilian variant,” is widespread. Data will continue to be collected over the next few weeks to determine CoronaVac’s effectiveness after the second dose.

Out of control : Brazil s COVID surge sparks regional fears | Coronavirus pandemic News

Rio de Janeiro, Brazil – Almost a year ago to the day, the jungle city of Manaus grabbed international headlines after a flood of COVID-19 deaths forced gravediggers to dig mass burials – catapulting the city into the centre of Brazil’s coronavirus outbreak. Those scenes are now being repeated throughout Brazil, where authorities are working day and night to bury the dead, with experts warning that the country’s funeral services could be the next to topple. Since the start of the year, an uncontrollable second wave has pushed Brazil over the 300,000 death mark. As the country continues to hit grim milestones – a record 4,247 deaths on Thursday alone – the entire South American nation is now the global COVID-19 epicentre, with experts warning that 5,000 Brazilians could lose their lives in a single day in April.

George still backs AstraZeneca vaccine

Article by Social Share As complications continue to unfold with the AstraZeneca COVID-19 vaccine, the latest being confirmation from the European drug regulators of linkage between the shot and rare blood clots, this country’s Chief Medical Officer Dr Kenneth George is standing by the safety of the jab developed by the UK-based pharmaceutical company. In an interview with the Weekend Nation, George contends that with serious limitations in options and with the benefits far outweighing the risk, there is no point trying to change the course which has already seen just over 63 000 people receiving their first dose of the vaccine in Barbados.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.